Edition:
United States

Mesoblast Ltd (MESO.OQ)

MESO.OQ on NASDAQ Stock Exchange Global Select Market

4.63USD
20 Nov 2018
Change (% chg)

-- (--)
Prev Close
$4.63
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
17,640
52-wk High
$8.74
52-wk Low
$4.58

Chart for

About

Mesoblast Limited is engaged in developing cell-based medicines. The Company has leveraged its technology platform, which is based on specialized cells known as mesenchymal lineage adult stem cells, to establish a portfolio of late-stage product candidates. Its allogeneic, off-the-shelf cell product candidates target advanced... (more)

Overall

Beta: 1.85
Market Cap(Mil.): $522.58
Shares Outstanding(Mil.): 99.47
Dividend: --
Yield (%): --

Financials

  MESO.OQ Industry Sector
P/E (TTM): -- 79.36 29.34
EPS (TTM): -0.38 -- --
ROI: -5.48 -0.30 13.58
ROE: -6.64 -2.98 15.11

Earnings vs. Estimates